Assessment of transthyretin cut-off values for a better screening of malnutrition: Retrospective determination and prospective validation.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
03 2021
Historique:
received: 06 02 2020
revised: 16 06 2020
accepted: 18 06 2020
pubmed: 16 7 2020
medline: 24 8 2021
entrez: 16 7 2020
Statut: ppublish

Résumé

The use of transthyretin (TTR, prealbumin) as a marker of malnutrition and the definition of associated cut-offs are a matter of debate. In order to clarify this issue, we performed a retrospective study and then a prospective validation one. In the first study, data from 23,617 consecutive patients from our University hospital were analysed. Using the 0.11 and 0.05 g/L cut-off values defined by the French Health Authority, only 3.13% and 0.49% appeared malnourished or severely malnourished indicating that these cut-off values are clearly inappropriate. In the prospective study, consecutive patients were stratified for normal (≥0.2 g/L) or low (<0.2 g/L) TTR, and normal (<15 mg/L) or high (≥15 mg/L) C-reactive protein, hence defining 4 groups (n = 50 to 57/group), and data were analysed according to nutritional status estimated from patient files. Receiver operating characteristic (ROC) curve of TTR level associated with malnutrition allowed setting cut-off values at 0.17 and 0.12 g/L for malnutrition and severe malnutrition respectively.

Identifiants

pubmed: 32665102
pii: S0261-5614(20)30328-9
doi: 10.1016/j.clnu.2020.06.017
pii:
doi:

Substances chimiques

Biomarkers 0
Prealbumin 0
C-Reactive Protein 9007-41-4

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

907-911

Informations de copyright

Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest None declared.

Auteurs

Sarah Dellière (S)

Service de Biochimie, Hôpital Cochin, APHP, Paris, France.

Lydia Pouga (L)

Service de Biochimie, Hôpital Cochin, APHP, Paris, France.

Nathalie Neveux (N)

Service de Biochimie, Hôpital Cochin, APHP, Paris, France; Laboratoire de Biologie de la Nutrition, EA4466 PRETRAM, Faculté de Pharmacie de Paris, Université de Paris, Paris, France.

Alain Hernvann (A)

Service de Biochimie, Hôpital Cochin, APHP, Paris, France.

Jean-Pascal De Bandt (JP)

Service de Biochimie, Hôpital Cochin, APHP, Paris, France; Laboratoire de Biologie de la Nutrition, EA4466 PRETRAM, Faculté de Pharmacie de Paris, Université de Paris, Paris, France.

Luc Cynober (L)

Service de Biochimie, Hôpital Cochin, APHP, Paris, France; Laboratoire de Biologie de la Nutrition, EA4466 PRETRAM, Faculté de Pharmacie de Paris, Université de Paris, Paris, France. Electronic address: luc.cynober@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH